Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Molecules ; 27(7)2022 Mar 30.
Artículo en Inglés | MEDLINE | ID: mdl-35408640

RESUMEN

The purpose of this study was to chemically compare samples of Mentha spicata (marketing byproducts, production byproducts, and export material), cultivated in the open field and under greenhouse, using an integrated approach by HPLC/DAD and GC/MS analysis. The presence of phenolic compounds was higher in the marketing byproducts cultivated in the open field. Marketing byproducts also had the highest amount of carvone. For this reason, this byproduct was selected as a candidate for the development of natural ingredients. With the best selected material, the optimization of simultaneous high-intensity ultrasound-assisted extraction processes was proposed for the recovery of the compounds of interest. This extraction was defined by Peleg's equation and polynomial regression analysis. Modeling showed that the factors amplitude, time, and solvent were found to be significant in the recovery process (p < 0.005). The maximum amount of compounds was obtained using 90% amplitude for 5 min and ethanol/water mixture (80:20) for extraction to simultaneously obtain phenolic and terpenoid compounds. This system obtained the highest amount of monoterpenoid and sesquiterpenoid compounds from the essential oil of M. spicata (64.93% vs. 84.55%). Thus, with an efficient and eco-friendly method, it was possible to optimize the extraction of compounds in M. spicata as a starting point for the use of its byproducts.


Asunto(s)
Mentha spicata , Mentha , Aceites Volátiles , Mentha/química , Mentha spicata/química , Monoterpenos/análisis , Aceites Volátiles/química , Fenoles , Fitoquímicos , Extractos Vegetales
2.
Molecules ; 26(24)2021 Dec 07.
Artículo en Inglés | MEDLINE | ID: mdl-34946510

RESUMEN

Methylxanthines and polyphenols from cocoa byproducts should be considered for their application in the development of functional ingredients for food, cosmetic and pharmaceutical formulations. Different cocoa byproducts were analyzed for their chemical contents, and skincare properties were measured by antioxidant assays and anti-skin aging activity. Musty cocoa beans (MC) and second-quality cocoa beans (SQ) extracts showed the highest polyphenol contents and antioxidant capacities. In the collagenase and elastase inhibition study, the highest effect was observed for the SQ extract with 86 inhibition and 36% inhibition, respectively. Among cocoa byproducts, the contents of catechin and epicatechin were higher in the SQ extract, with 18.15 mg/100 g of sample and 229.8 mg/100 g of sample, respectively. Cocoa bean shells (BS) constitute the main byproduct due to their methylxanthine content (1085 mg of theobromine and 267 mg of caffeine/100 g of sample). Using BS, various influencing factors in the extraction process were investigated by response surface methodology (RSM), before scaling up separations. The extraction process developed under optimized conditions allows us to obtain almost 2 g/min and 0.2 g/min of total methylxanthines and epicatechin, respectively. In this way, this work contributes to the sustainability and valorization of the cocoa production chain.


Asunto(s)
Antioxidantes/aislamiento & purificación , Cacao/química , Catequina/aislamiento & purificación , Inhibidores Enzimáticos/aislamiento & purificación , Extractos Vegetales/aislamiento & purificación , Xantinas/aislamiento & purificación , Antioxidantes/química , Antioxidantes/farmacología , Catequina/química , Catequina/farmacología , Colagenasas/metabolismo , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/farmacología , Recuperación de Fluorescencia tras Fotoblanqueo , Elastasa Pancreática/antagonistas & inhibidores , Elastasa Pancreática/metabolismo , Extractos Vegetales/química , Extractos Vegetales/farmacología , Xantinas/química , Xantinas/farmacología
3.
Food Chem ; 293: 291-298, 2019 Sep 30.
Artículo en Inglés | MEDLINE | ID: mdl-31151614

RESUMEN

Garcinia madruno is a neotropical tree characterized by its exotic fruit and its functional compounds. The aim of this study was to evaluate the expression and variability of the chemical markers of G. madruno according to the part of the plant used, the origin and the ripeness stage by applying chemometric tools. A total of 167 samples were evaluated, and 27 compounds were quantified per sample. The expression of amentoflavone, morelloflavone-type biflavonoids and polyisoprenylated benzophenones (PIBs) promoted intergroup differentiation, whereas the expression of GB-2a-type biflavonoids promoted intragroup cluster generation. Epicarp was the main source of biflavonoids and the secondary source of PIBs, with values up to 25% in some individuals. The origin of the fruit significantly impacted the expression of metabolites, whereas the ripeness stage did not. The results indicate that epicarp is a good source of functional compounds and, with appropriately agronomic development, could be improved even more.


Asunto(s)
Garcinia/clasificación , Benzofenonas/análisis , Biflavonoides/análisis , Frutas/química , Garcinia/química , Humanos , Extractos Vegetales/química , Clima Tropical
4.
Pharmacol Res ; 129: 128-138, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29229355

RESUMEN

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is pathologically characterized by the deposition of ß-amyloid (ßA) peptides in senile plaques and neurofibrillary tangles in the brain. Flavonoids have recently been used to prevent and treat a variety of neurodegenerative diseases, but little is known about bioflavonoids. In this study, we evaluate whether a biflavonoid fraction (BF) exerts neuroprotective effects on an aged triple transgenic mouse mode of AD (3xTg-AD). Then, 21-24-month-old 3xTg AD mice were i.p. injected with 25mg/kg of a BF from Garcinia madruno composed of morelloflavone (65%), volkensiflavone (12%), GB 2a (11%), fukugiside (6%) and amentoflavone (0.4%) every 48h for 3 months. The BF treatment reduced ßA deposition in different regions of the brain (the hippocampus, entorhinal cortex and amygdala), reduced ßA1-40 and ßA1-42 levels, BACE1-mediated cleavage of APP (CTFß), tau pathology, astrogliosis and microgliosis in the brains of aged 3xTg-AD mice. Although the BF treatment weakly improved learning, animals treated with BF spent more time in the open arms of the elevated plus maze test and displayed greater risk assessment behavior than the control groups. In summary, the BF reverses histopathological hallmarks and reduces emotional disorders in the 3xTg-AD mouse model, suggesting that the biflavonoids from G. madruno represent a potential natural therapeutic option for AD if its bioavailability is improved.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Biflavonoides/uso terapéutico , Garcinia , Fármacos Neuroprotectores/uso terapéutico , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/metabolismo , Animales , Biflavonoides/farmacología , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Modelos Animales de Enfermedad , Femenino , Aprendizaje/efectos de los fármacos , Masculino , Ratones Transgénicos , Fármacos Neuroprotectores/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA